|
|
|
|
|
1
|
Managed Markets Account Management: Assessing the Performance of Account Executives |
Oct 2009 |
$4,210.00 |
|
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth study to: identify common performance measurement practices across geographies and
more...
Published by: Best Practices, LLC
|

|
|
2
|
Developing Managed Care Pull-Through Excellence |
Oct 2009 |
$5,200.00 |
|
STUDY OVERVIEW
In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies but also to "pull through" the business and increase market share after a win. To
more...
Published by: Best Practices, LLC
|

|
|
3
|
Best Practices for Post-Marketing Surveillance of Adverse Events within the U.S. |
Sep 2009 |
$2,895.00 |
|
STUDY OVERVIEW
Medical and scientific progress has been enormous in the past decades. However, this has also raised several safety issues leading to increased vigilance on bio-pharma companies by the U.S. Food and Drug Administration
more...
Published by: Best Practices, LLC
|

|
|
4
|
Best Practices in Recruitment for Medical Education Programs |
Jul 2009 |
$3,895.00 |
|
STUDY OVERVIEW
Non-Continuing Medical Education (non-CME) programs, also called promotional education programs, are an important tool to educate and inform physicians, pharmacists, nurses and other healthcare practitioners.
New regulations and guidelines regarding medical education
more...
Published by: Best Practices, LLC
|

|
|
5
|
Best Practices for Internal Communications Regarding Brands & Disease States |
Jul 2009 |
$7,400.00 |
|
STUDY OVERVIEW
When a promising new pharmaceutical product fails to meet expectations, poor brand communications may be a contributing cause. Successful brand leaders today must understand how and when to deliver complex key messages to
more...
Published by: Best Practices, LLC
|

|
|
6
|
Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics |
Jul 2009 |
$3,395.00 |
|
STUDY OVERVIEW
Forward-thinkers in the biopharmaceutical industry recognize employers as true payers of healthcare, ready to assume a more active role in healthcare decision making. As a result, many companies are seeking ways to
more...
Published by: Best Practices, LLC
|

|
|
7
|
Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights |
Jul 2009 |
$4,600.00 |
|
Today’s physicians are rapidly losing their influence over patients’ drug utilization decisions and unfortunately a large number of bio-pharmaceutical companies have failed to recognize that third-party payers, such as government and commercial organizations, now control
more...
Published by: Best Practices, LLC
|

|
|
8
|
Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging and Supporting Patients |
Jul 2009 |
$4,575.00 |
|
STUDY OVERVIEW
With so much riding on the consumers’ acceptance of a product, it is only logical to have in place initiatives that focus on the unfulfilled needs of the consumer population when designing marketing
more...
Published by: Best Practices, LLC
|

|
|
9
|
Medical Affairs Resources, Structures and Trends |
Jul 2009 |
$4,100.00 |
|
STUDY OVERVIEW
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions - including publications, KOL programs, grants, and medical education (CME) that have been impacted in recent years
more...
Published by: Best Practices, LLC
|

|
|
10
|
Optimizing Key Opintion Leader Relationships: Best Practices in KOL Management |
Apr 2009 |
$5,200.00 |
|
STUDY OVERVIEW
The advocacy of Key Opinion Leaders (KOLs) has proven to be among the most effective and critical means of building product awareness in the medical and scientific communities.
Indeed, KOL relationship management
more...
Published by: Best Practices, LLC
|

|
|
11
|
Using Public Relations to Launch, Grow and Extend Your Brands |
Mar 2009 |
$6,800.00 |
|
Savvier consumers and competition from generic drugs have made commercial success, whether at market entry or during brand maturity, more elusive. At the same time, new technologies have greatly expanded the ability of cost-efficient
more...
Published by: Best Practices, LLC
|

|
|
12
|
Building an Effective Regulatory Relationship with the FDA |
Feb 2009 |
$7,000.00 |
|
Though science remains the fundamental engine behind successful New Drug Applications, effective communication between pharmaceutical companies and the FDA at each stage of this process stands as a vital ingredient in securing approval for a
more...
Published by: Best Practices, LLC
|

|
|
13
|
Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders |
Feb 2009 |
$2,800.00 |
|
STUDY OVERVIEW
As companies compete for the attention of physicians, key opinion leaders (KOLs) and thought leaders, they increasingly use medical science liaisons (MSLs) to build and strengthen KOL relationships. As laws continue to
more...
Published by: Best Practices, LLC
|

|
|
14
|
Pharmaceutical Science Exellence: CMC Activities, Resources, and Performance |
Jan 2009 |
$10,500.00 |
|
STUDY OVERVIEW
Best Practices, LLC conducted this study to better understand resource and investment levels, expertise, and activities in global (pre-launch) Chemistry, Manufacturing and Control (CMC) operations in top pharmaceutical companies. This data-rich study
more...
Published by: Best Practices, LLC
|

|
|
15
|
Winning Brand Team Management: Best Practices in Leadership, Work Practices, Structure and Performance Management |
Jan 2009 |
$4,115.00 |
|
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate, it is only
more...
Published by: Best Practices, LLC
|

|
|
16
|
Best Practices for Valuing Internal Consulting Organizations |
Dec 2008 |
$3,700.00 |
|
Many leading companies have developed and staffed an internal consulting organization for various reasons, but in times of economic adversity, as costs are scrutinized, the value of all functions within companies are being questioned.
more...
Published by: Best Practices, LLC
|

|
|
17
|
Performance Benchmark: Optimizing Marketing Staff Levels to Drive Growth |
Dec 2008 |
$3,500.00 |
|
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
The benchmarks developed by this assessment are prepared
more...
Published by: Best Practices, LLC
|

|
|
18
|
Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight |
Dec 2008 |
$3,995.00 |
|
STUDY OVERVIEW
Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly influential Managed Markets sector. In response, savvy bio pharmaceutical companies are seeking to
more...
Published by: Best Practices, LLC
|

|
|
19
|
The High Performing Pharmaceutical District Sales Manager: Current Trends & Future Directions |
Nov 2008 |
$7,895.00 |
|
Snapshot
This research is focused on several major topic areas: (1) Impact of Sales Force Transformation Trends on Pharmaceutical District Sales Managers, (2) Evolution of the District Sales Manager Role, (3) Key Skills &
more...
Published by: Best Practices, LLC
|

|
|
20
|
Cymbalta Case Study: Successfully Entering a Crowded Market with a New Mechanism of Action |
Nov 2008 |
$4,495.00 |
|
KEY TOPICS
Business Challenges Addressed
Market Entry Strategy and Insights
Use of Third-Party Expertise
Influencing Key Opinion Leaders
Tactics to Drive Success
Focus on
more...
Published by: Best Practices, LLC
|

|
|
21
|
Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone |
Nov 2008 |
$5,252.00 |
|
In today’s fast-changing, high-pressure marketplace, the Competitive Intelligence (CI) function helps companies anticipate external threats and opportunities in a timely manner so companies can respond strategically. World-class companies maximize CI success by providing sufficient
more...
Published by: Best Practices, LLC
|

|
|
22
|
Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection Within Approved Guidelines |
Nov 2008 |
$3,995.00 |
|
Research Overview
Data for this study were conducted in an online survey instrument and through eight in-depth interviews with CI leaders and practitioners.
Study Objective and Methodology
The objective of this benchmarking study is
more...
Published by: Best Practices, LLC
|

|
|
23
|
Requip Case Study: Life Cycle Management - Reinvigorating a Mature Brand |
Nov 2008 |
$2,995.00 |
|
KEY TOPICS
Coordinated Marketing Efforts
Patient Advocacy
Disease Awareness
Condition Branding
Market Preparation
Disease State Critical Success Factors
Managing Disease Perception
more...
Published by: Best Practices, LLC
|

|
|
24
|
Pharmaceutical New Product Commercialization: Preparing for Market Success |
Nov 2008 |
$7,995.00 |
|
Study Snapshot
Best Practices, LLC examined how other biopharmaceutical companies’ Early-Stage Commercialization functions are structured, how leaders of these groups manage their functions, and for what activities and roles Early-Stage Commercialization leaders have responsibility. The
more...
Published by: Best Practices, LLC
|

|
|
25
|
Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success |
Nov 2008 |
$4,500.00 |
|
Best Practices, LLC used both field surveys and interviews to complete this study. In all, 19 sales and marketing leaders contributed data. In-depth interviews were conducted with leaders from six of the participating
more...
Published by: Best Practices, LLC
|

|
|
|
|
|